BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26261590)

  • 1. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.
    Jiang YX; Li PA; Yang SW; Hao YX; Yu PW
    Int J Clin Exp Pathol; 2015; 8(6):7002-8. PubMed ID: 26261590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
    Zhao P; Lu Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
    Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS
    Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
    Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
    Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
    Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
    Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
    Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
    Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
    Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
    J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of early growth response-1 in human gastric cancer and its relationship with tumor cell behaviors and prognosis.
    Myung E; Park YL; Kim N; Chung CY; Park HB; Park HC; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
    Pathol Res Pract; 2013 Nov; 209(11):692-9. PubMed ID: 24011795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.